CRP has received considerable attention as a diagnostic and prognostic marker in autoimmune diseases (2, 3), cardiovascular diseases (4–6), chronic kidney disease (7), cancer (8) and COVID-19 (9, 10) as well as for guiding therapy (8, 11). This evidence concerns the gene CRP and COVID-19.